FGF21 is paradoxically increased in insulin-resistant states such as obesity or type 2 diabetes; this suggests either a resistance to FGF21 effects or a compensatory response to these metabolic disarrangements (Zhang et al., 2008; Cuevas-Ramos et al., 2010). Here, FGF21 is linked to type 2 diabetes mellitus.